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摘要
目的:研究糖尿病患者中央角膜厚度与血糖浓度(糖化血
红蛋白,HbA1c)的关系。
方法:对52 例 HbA1c>7%的2 型糖尿病患者行单中心、前
瞻性临床试验。 结果显示,平均随访 6mo 后,血糖浓度控
制效果不佳。 记录性别、病程,采用超声波测厚仪测量中
央角膜厚度,取三次测量的平均值。 患者在内分泌科门诊
进行治疗。 当 HbA1c臆7%时,再次记录中央角膜厚度,并
比较治疗前后的 HbA1c 水平和中央角膜厚度。
结果:治疗前后平均中央角膜厚度分别为 552.30依29.26滋m
和542.36依27.20滋m,平均 HbA1c 水平分别为(9.36依1.79)%
和(6.45依0. 70)%,差异显著(P=0. 0001,配对 t 检验)。
结论:中央角膜厚度随 HbA1c 水平的降低(血糖控制良
好)而显著下降,但高血糖和正常血糖患者中央角膜厚度
平均值均在正常范围内。 因此,在对糖尿病患者进行眼部
检查时应注意 HbA1c。
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Abstract
誗AIM: To study the central corneal thickness (CCT) in
diabetic patients and its relationship with glycemic control
(HbA1c levels).
誗 METHODS: Single - centre, prospective, clinical trial
with a mean of 6 - month follow - up examination. We
included 52 patients with type 2 diabetes mellitus (DM)
whose HbA1c levels were above 7%, indicating poor
glycemic control. Sex of patients, and duration of DM
were recorded. CCT was determined with ultrasound
pachymeter. Each CCT measurement was the mean of 3
pachymeter readings. Then the patients were treated by
the endocrinology clinic. When glycemic control was
achieved ( HbA1c 臆 7%), CCT measurements were
recorded again. HbA1c and CCT before and after
treatment were compared.
誗RESULTS: Mean CCT before treatment was 552. 30 依
29郾 26滋m, and mean HbA1c was (9. 36 依 1. 79)%. Mean
CCT after treatment was 542. 36 依 27. 20滋m, and mean
HbA1c was (6.45依0. 70)%. The difference between these
two values was statistically significant (P=0.0001, paired t
test).
誗CONCLUSION: Even though mean hyperglycemic and
euglycemic CCT measurements were in normal range,
CCT decreases significantly by lowering HbA1c level
( good glycemic control). Therefore, glycemic status
(HbA1c) should be considered when examining the eye
of diabetic patients.
誗 KEYWORDS: central corneal thickness; diabetes
mellitus; hemoglobin A1c; intraocular pressure; treatment
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INTRODUCTION
C
orneal abnormalities that occur in diabetes mellitus
( DM ) are termed as diabetic keratopathy. Several
clinical studies have shown that patients with diabetes have
abnormalities such as higher corneal autofluorescence, lower
corneal sensitivity, greater corneal thickness, less endothelial
density
[1,2].
Corneal endothelium plays a major role in maintaining the
optical transparency of the cornea. These cells have limited
mitotic capacity and chronic metabolic changes on the cellular
level seems to affect the monolayer of corneal endothelial
cells
[3,4].
Some previous studies showed increased central corneal
thickness ( CCT) in diabetic patients compared to non -
diabetic control groups
[1,2], but some others showed no
difference in CCT between diabetic and control groups
[3,4].
We have not seen any previous study comparing CCT before
and after treatment of the same diabetic patients. The purpose
of this study was to evaluate CCT in diabetic patients with
poor glycemic control and whether there will be a significant
change in these measurements after successful control of
hyperglycemia.
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A clinical prospective study, including 52 patients with type
II diabetes mellitus whose serum HbA1c levels were above
7%, was performed.
An informed consent was obtained from all patients. The study
protocol was approved by the institution蒺s ethics commitee in
accordance with the Declaration of Helsinki.
Ophthalmic examination including medical history,
biomicroscopic examination of anterior segment, dilated
fundus examination with 90D lens were performed. Any
patients having history of ocular disease, previous ophthalmic
surgery, using topical ocular medications and wearing contact
lenses were exluded from study. Age and sex of patients, and
duration of DM were recorded.
Corneal thickness was determined with ultrasound pachymeter
(PacScan 300AP, Sonomed/ Escalon
TM). Measurements were
taken from both eyes during morning hours. Each CCT
measurement was the mean of 3 pachymeter readings.
Measurements were completed on each eye and these were
averaged to provide a single value as described in a previous
study done by Lee et al
[5]. Before doing this, we made a
Pearson correlation test to show the correlation between the
measurements of both eyes.
Then the patients were treated by the endocrinology clinic.
The follow-up of patients was done by different physicians at
the endocrinology clinic. After mean follow-up of 6mo (4-
8mo) when glycemic control was achieved (HbA1c臆7%,
euglycemic status), CCT measurements were recorded again.
HbA1c and CCT before and after treatments were compared.
Also association between CCT and sex, duration of DM, and
treatment modalities were studied.
Statistical Analysis摇 Statistical analysis were performed by
paired t test, independent samples t test, and P values 0. 05
or less were considered statistically significant. Values are
shown as mean依SD.
RESULTS
There were 52 diabetic patients with poor glycemic control
(HbA1c逸7%) in study group. Mean age was 58.75 (46-73)
years and there were 27 men (51.9%) and 25 women (48.1%).
Duration of diabetes was more than 10 years in 32 patients
(61.5%).
Antidiabetic treatment consisted of insulin in 24 patients
(46郾 2%) and oral antidiabetics in 28 patients (53. 8%).
At the beginning mean HbA1c level ( hyperglycemic
condition) was (9. 36依1.79)% and after achieving glycemic
control ( euglycemic condition ) mean HbA1c level was
(6郾 45% 依0.70)%.
Pearson correlation was 0.88 between the CCT of the right eye
and CCT of the left eye. This value showed that CCT
measurement of any eye could be used. So we used the single
average value. Mean CCT before treatment ( hyperglycemic
status) was 552. 30依29. 26滋m with range (504-604滋m)
Table 1摇 Comparison of the patients蒺 mean HbA1c and CCT
values before and after successful treatment of type 2 diabetes
mellitus 軃 x依s
Patients (n=52) Before treatment After treatment P
HbA1c values (%) 9.36依1.79 6.45依0. 70 10.0001
CCT (滋m) 552. 30依29.26 542. 36依27. 20 10.0001
CCT: Central corneal thickness.
1Statistically significant; paired t test.
and after diabetic treatment (euglycemic status) was 542.36依
27. 20滋m with range (495 - 596滋m). The difference was
statistically significant (P=0.0001, paired t test) (Table 1).
No statistically significant difference was found in terms of
gender, duration of DM and antidiabetic treatment modalities
(P=0. 53; P=0. 34; P=0.54 respectively) (Table 2).
DISCUSSION
Various types of corneal disorders, termed diabetic
keratopathy, are common in persons with DM. Reduced tear
production, decreased corneal sensitivity, and changes in
endothelial morphology and function, alterations of corneal
epithelial basement membrane and increased corneal thickness
have been documented in diabetic patients
[6].
CCT changes associated with DM have been reported in
various studies
[5-10]. Lee et al
[5] measured CCT of diabetic
patients and found higher CCT values in patients with DM
compared with control group. They also found that CCT was
thicker in patients with diabetes of over 10 years. These
changes may be associated with blood glucose
concentrations
[11]. We have found a slight increase in CCT of
our diabetic patients with more than 10 years蒺 duration when
compared to less than 10 years蒺 duration, but it was not
statistically significant.
Unlike previous studies which comparing CCT in diabetic
patients and in control groups, we assessed the change in CCT
measurements in the same diabetic patient group before and
after achieving a good glycemic control
[2,7,8].
The results of our study showed that mean CCT was thicker in
hyperglcemic condition than euglycemic condition in the same
patients.
In our study, we did not find a significant difference in CCT
in relation to the duration of diabetes, although the mean CCT
was thicker in patients with diabetes of over 10 years.
Interestingly, mean initial HbA1c level of patients with
diabetes of over 10 years was less than the patients with
diabetes of shorter duration. This finding may be explained by
shorter life span of erythrocytes due to chronic metabolic
disease. As a result, young red blood cells which are devoid
of glucose accumulation enter into the circulation and lower
HbA1c concentration
[12].
Choo et al
[8] found that endothelial cell density in diabetic
group was significantly less than that in control group, and
CCT was higher in diabetic patients although it was not
significant. Also they found that duration of DM and HbA1c
levels were not significantly correlated with corneal endothelial
findings.
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of diabetes
Patient groups n (%)
Initial HbA1c
(%)
Last HbA1c
(%)
1P
Initial CCT
(滋m)
Last CCT
(滋m)
1P
Gender
摇 M 27 (51. 9) 9. 77依2. 00 6. 50依0. 74
30. 0001 554. 74依31. 73 542. 70依30. 35
30. 0001
摇 F 25 (48. 1) 8. 92依1. 44 6. 39依0. 68
30. 0001 549. 68依26. 74 542. 00依23. 97
30. 0001
摇
2P 0. 08 0. 57 0. 53 0. 92
Diabetes duration
摇 <10a 20 (38. 5) 10. 03依2. 27 6. 67依0. 69
30. 0001 547. 40依26. 69 536. 45依24. 73
30. 0001
摇 逸10a 32 (61. 5) 8. 94依1. 28 6. 30依0. 68
30. 0001 555. 37依30. 77 546. 06依28. 39
30. 0001
摇
2P
30. 03 0. 07 0. 34 0. 21
Therapy of diabetes
摇 Insulin 24 (46. 2) 10. 04依1. 91 6. 58依0. 73
30. 0001 549. 58依29. 12 538. 12依27. 08
30. 0001
摇 Oral anti-diabetic 28 (53. 8) 8. 77依1. 48 6. 33依0. 67
30. 0001 554. 64依29. 71 546. 00依27. 27
30. 0001
摇
2P
30. 01 0. 19 0. 54 0. 30
CCT: Central corneal thickness.
1P: Comparison between initial and last measurements was made by paired-t test;
2P: Comparison between
initial-initial and last-last measurements was made by independent samples t test;
3Statistically significant difference.
Storr-Paulsen et al
[2] showed a significant increase in CCT in
type 2 diabetic group (538 vs 546滋m) and no correlation with
HbA1c level. They also found that in diabetic group, lower
endothelial cell count were associated with higher HbA1c
values (P臆0.05).
Ozdamar et al
[7] found significantly greater CCT measurements
in diabetic eyes compared with control eyes. The mean CCT
was greater in eyes with proliferative diabetic retinopathy
(PDR) compared with those with non proliferative diabetic
retinopathy and no diabetic retinopathy, but difference was
not statistically significant. This may be explained as patients
devoloping PDR, evidently have bad glycemic control.
Su and co-workers examined the relationship of diabetes and
hyperglycemia with CCT and demonstrated mean CCT was
6郾 5滋m thicker in diabetic patients than in persons without
diabetes. And this difference was significant (P臆0.001)
[13].
There are some studies investigating the effects of glycemic
control on refraction in diabetic patients. Huntjens et al
[14],
and Li et al
[15], showed that short term variation in CCT was
similar in control subjects and the diabetic patients. There
was no significant difference between groups, even though the
diabetic corneas were thicker compared to controls. This
suggests that short term changes in blood glucose levels do not
have a significant effect on CCT in diabetic patients
[14,15].
In our study we found a correlation between corneal thickness
and the higher HbA1c values. HbA1c reflects the mean blood
glucose level during the preceding 6 to 8wk, it reflects the
patients蒺 general tendency to diabetes control.
We found that CCT decreased significantly with the change
from hyperglycemic status to euglycemic status as reflected by
the measurements of HbA1c, in our diabetic patients. We
think that this finding will be useful in clinical practice in the
evaluation of IOP measurements of diabetic patients.
Patients with type 2 DM have an increased risk of developing
open angle glaucoma. Diabetes affects corneal biomechanics,
this results in lower corneal hysteresis values than those in
healthy control subjects
[16,17]. This may cause high intraocular
pressure ( IOP ) measurements. Goldman applanation
tonometry ( GAT) estimates IOP by measuring the force
required to flatten an area of cornea, so corneal characteristics
including its thickness can affect IOP measurements. Thicker
central corneas may lead to overestimation of the real IOP in
diabetic patients
[18]. Biswas et al
[19] confirmed this correlation
between increasing IOP and increasing CCT as measured by
GAT in diabetic patients.
It was shown that every 10滋m change in CCT could yield
0. 47 - 0. 98mmHg deviation in IOP measurements by non
contact tonometer
[20], and 0. 28 - 0. 37mmHg deviation by
GAT
[21].
In conclusion, we found that, even though mean
hyperglycemic and euglycemic CCT measurements were in
normal range, CCT decreases significantly by lowering HbA1c
level (good glycemic control). There is no previous report
known to us that evaluated the change in CCT between
diabetic patients with poor glycemic control and the same
patients after achieving good glycemic control. Glycemic
status (HbA1c) should be considered when examining the eye
of diabetic patients.
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